Peetz Christopher 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Peetz Christopher（CIK 1614740）在 2 家公司共报告 36 笔 SEC Form 4 内部人交易（最近一笔 2026-10-06）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-06 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 买入 | 5,305 | $101,803 |
| 2026-10-06 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 买入 | 6,892 | $109,376 |
| 2026-09-03 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 买入 | 30,000 | $88,080 |
| 2026-09-03 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 8,312 | $815,241 |
| 2026-09-03 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 21,688 | $2.1M |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 买入 | 20,000 | $58,720 |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 11,683 | $1.2M |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 6,017 | $597,187 |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 2,300 | $230,322 |
| 2026-07-17 | Arcutis Biotherapeutics, Inc. (ARQT) | 董事 | 买入 | 4,315 | $0 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 4,181 | $511,504 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 12,134 | $1.5M |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 买入 | 20,000 | $58,720 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 1,975 | $244,386 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 1,710 | $213,391 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 买入 | 30,000 | $88,200 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 2,602 | $246,253 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 16,595 | $1.6M |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 6,926 | $665,935 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 1,973 | $192,486 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 1,021 | $100,262 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 883 | $88,000 |
| 2026-03-17 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 买入 | 25,000 | $0 |
| 2026-03-17 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 买入 | 50,000 | $0 |
| 2026-03-17 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | 卖出 | 40,985 | $3.8M |
来源：SEC Form 4 申报文件 · 截至 2026-10-06